Metraipolis › archive › dc_72d16bb51b93

Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy — Europe PMC PMID:42733245

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42733245
DOI
10.1002/advs.77572
License (as archived)
solo-consultazione
Archived
2026-10-10T01:48:50.941Z
SHA-256 of the archived text
31c871cd13d61f3baea16fc51efe19f4da9f4ea4e5296341508f02b3e05b5d56
Stable URL of this page
https://metraipolis.com/documento/dc_72d16bb51b93

How to cite

Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy — Europe PMC PMID:42733245 — Europe PMC (en), https://europepmc.org/article/MED/42733245 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72d16bb51b93 (Metraipolis archive dc_72d16bb51b93, sha256 31c871cd13d61f3baea16fc51efe19f4da9f4ea4e5296341508f02b3e05b5d56)
BibTeX
@misc{dc72d16bb51b93,
  title = {Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy — Europe PMC PMID:42733245},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42733245},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72d16bb51b93; sha256 31c871cd13d61f3baea16fc51efe19f4da9f4ea4e5296341508f02b3e05b5d56},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42733245. Agents can read the archived copy with the MCP tool read_document.